1. Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis

   • T. Saito
   • J. M. Sterbenz
   • K. C. Chung

   Review 02 August 2017 Pages: 3289 - 3300

   

2. Inflammatory diseases and bone fragility

   • K. Briot
   • P. Geusens
   • C. Roux

   Review 15 September 2017 Pages: 3301 - 3314

   

3. Global dietary calcium intake among adults: a systematic review

   • E. M. Balk
   • G. P. Adam
   • for the International Osteoporosis Foundation Calcium Steering Committee

   Review Open access 12 October 2017 Pages: 3315 - 3324

   

4. Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS

   • L. Zhou
   • X. Chen
   • F. He

   Original Article 27 September 2017 Pages: 3325 - 3337

   

5. Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study

   • C. Roux
   • G. Baron
   • T. Thomas

   Original Article 29 August 2017 Pages: 3339 - 3345

   

6. Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study

   • V. Schwetz
   • C. Schnedl
   • K. Amrein

   Original Article Open access 25 August 2017 Pages: 3347 - 3354

7. Increasing alkali supplementation decreases urinary nitrogen excretion when adjusted for same day nitrogen intake

   • L. Ceglia
   • B. Dawson-Hughes

   Original Article 25 August 2017 Pages: 3355 - 3359

   

8. Longevity of daily oral vitamin D3 supplementation: differences in 25OHD and 24,25(OH)2D observed 2 years after cessation of a 1-year randomised controlled trial (VICtORy RECALL)

   • H. M. Macdonald
   • A. Gryka
   • A. D. Wood

   Original Article 15 September 2017 Pages: 3361 - 3372

   

9. Low physical activity is related to clustering of risk factors for fracture—a 2-year prospective study in children

   • S. Stenevi Lundgren
   • B. E. Rosengren
   • M. K. Karlsson

   Original Article Open access 15 September 2017 Pages: 3373 - 3378

10. Validity, reliability, and responsiveness to change of the “Osteoporosis and You” knowledge scale

    • V. T. Nguyen
    • S. W. Edmonds
    • F. D. Wolinsky

    Original Article 07 September 2017 Pages: 3379 - 3388

    

11. Non-participation in systematic screening for osteoporosis—the ROSE trial

    • M. J. Rothmann
    • S. Möller
    • K. H. Rubin

    Original Article 05 September 2017 Pages: 3389 - 3399

    

12. Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program

    • H. Ansari
    • D. E. Beaton
    • the Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team

    Original Article 10 September 2017 Pages: 3401 - 3406

13. Maternal vitamin D and offspring trabecular bone score

    • N. K. Hyde
    • S. L. Brennan-Olsen
    • J. A. Pasco

    Original Article 03 September 2017 Pages: 3407 - 3414

    

14. Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan

    • O. Kaewboonchoo
    • F. C. Sung
    • C. T. Kuo

    Original Article 05 September 2017 Pages: 3415 - 3420

    

15. Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity

    • A. B. Pedersen
    • V. Ehrenstein
    • H. T. Sørensen

    Original Article 05 September 2017 Pages: 3421 - 3430

16. Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk

    • M. A. Mignot
    • N. Taisne
    • J. Paccou

    Original Article 05 September 2017 Pages: 3431 - 3438

    

17. Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada

    • O. L. Tseng
    • M. G. Dawes
    • M. L. McBride

    Original Article 09 October 2017 Pages: 3439 - 3449

    

18. Gender-specific association between dietary acid load and total lean body mass and its dependency on protein intake in seniors

    • A. M. Faure
    • K. Fischer
    • H. A. Bischoff-Ferrari

    Original Article 02 October 2017 Pages: 3451 - 3462

    

19. Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study

    • L. Malmgren
    • F. McGuigan
    • K. E. Akesson

    Original Article Open access 16 October 2017 Pages: 3463 - 3473

    

20. Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process

    • C. Lavet
    • G. Mabilleau
    • P. Ammann

    Original Article 28 September 2017 Pages: 3475 - 3487

    

21. Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease

    • S. Herrera
    • R. Soriano
    • A. Diez-Perez

    Short Communication 25 August 2017 Pages: 3489 - 3493

    

22. Self-perception of fracture risk: what can it tell us?

    • A. E. Litwic
    • J. E. Compston
    • Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators

    Short Communication 31 August 2017 Pages: 3495 - 3500

    

23. Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise

    • N. Binkley
    • R. Besuyen
    • D. Hans

    Short Communication 10 October 2017 Pages: 3501 - 3513

    

24. Assessing impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery

    • Y.-Y. Liu
    • F.-S. Xue
    • H.-X. Li

    Letter 28 August 2017 Pages: 3515 - 3516